BSTC - BioSpecifics Technologies Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
39.03
-0.92 (-2.30%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close39.95
Open39.88
Bid34.13 x 100
Ask47.34 x 100
Day's Range38.81 - 40.40
52 Week Range38.51 - 58.79
Volume23,356
Avg. Volume25,927
Market Cap280.596M
Beta2.13
PE Ratio (TTM)24.55
EPS (TTM)1.59
Earnings DateMay 11, 2017 - May 12, 2017
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est65.00
Trade prices are not sourced from all markets
  • ImmunoGen (IMGN) Soars: Stock Adds 10.3% in Session
    Zacks20 days ago

    ImmunoGen (IMGN) Soars: Stock Adds 10.3% in Session

    ImmunoGen (IMGN) saw a big move last session, as its shares jumped more than 10% on the day, amid huge volumes.

  • RedHill Biopharma (RDHL) in Focus: Stock Moves 10.2% Higher
    Zacks22 days ago

    RedHill Biopharma (RDHL) in Focus: Stock Moves 10.2% Higher

    RedHill Biopharma (RDHL) was a big mover last session, as the company saw its shares rise more than 10% on the day.

  • PR Newswirelast month

    BioSpecifics Technologies Corp. to Present at the NobleCon14 Conference

    BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for thirteen clinical indications to date. Injectable collagenase is marketed as XIAFLEX® in the U.S. for the treatment of Dupuytren's contracture and Peyronie's disease by BioSpecifics' partner, Endo International plc (Endo).

  • Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : December 18, 2017
    Capital Cube2 months ago

    Biospecifics Technologies Corp. breached its 50 day moving average in a Bullish Manner : BSTC-US : December 18, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Biospecifics Technologies Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Biospecifics Technologies Corp. : December 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Biospecifics Technologies Corp. Here are 5 ETFs with the largest exposure to BSTC-US. Comparing the performance and risk of Biospecifics Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • New Strong Sell Stocks for December 6th
    Zacks3 months ago

    New Strong Sell Stocks for December 6th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017
    Capital Cube3 months ago

    Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q3, 2017 By the Numbers : December 5, 2017

    Categories: Yahoo FinanceGet free summary analysis Biospecifics Technologies Corp. reports financial results for the quarter ended September 30, 2017. We analyze the earnings along side the following peers of Biospecifics Technologies Corp. – AbbVie, Inc., Horizon Pharma plc, Radius Health Inc, Abbott Laboratories, Eli Lilly and Company and Alder Biopharmaceuticals, Inc. (ABBV-US, HZNP-US, RDUS-US, ABT-US, LLY-US and ... Read more (Read more...)

  • New Strong Sell Stocks for December 1st
    Zacks3 months ago

    New Strong Sell Stocks for December 1st

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Should You Be Tempted To Buy BioSpecifics Technologies Corp (BSTC) Because Of Its PE Ratio?
    Simply Wall St.3 months ago

    Should You Be Tempted To Buy BioSpecifics Technologies Corp (BSTC) Because Of Its PE Ratio?

    BioSpecifics Technologies Corp (NASDAQ:BSTC) trades with a trailing P/E of 26.4x, which is lower than the industry average of 26.9x. Although some investors may jump to the conclusion that thisRead More...

  • New Strong Sell Stocks for November 27th
    Zacks3 months ago

    New Strong Sell Stocks for November 27th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Monday

  • New Strong Sell Stocks for November 22nd
    Zacks3 months ago

    New Strong Sell Stocks for November 22nd

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Wednesday

  • New Strong Sell Stocks for November 17th
    Zacks3 months ago

    New Strong Sell Stocks for November 17th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

  • Associated Press3 months ago

    BioSpecifics posts 3Q profit

    The Lynbrook, New York-based company said it had net income of 37 cents per share. The biopharmaceutical company posted revenue of $6.5 million in the period. BioSpecifics shares have fallen 21 percent ...

  • PR Newswire3 months ago

    BioSpecifics Technologies Corp. Reports Third Quarter 2017 Financial Results

    LYNBROOK, N.Y. , Nov. 10, 2017 /PRNewswire/ -- BioSpecifics Technologies Corp. (NASDAQ: BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first ...

  • Capital Cube3 months ago

    ETFs with exposure to Biospecifics Technologies Corp. : November 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Biospecifics Technologies Corp. Here are 5 ETFs with the largest exposure to BSTC-US. Comparing the performance and risk of Biospecifics Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • PR Newswire3 months ago

    BioSpecifics Technologies Corp. to Present at the Stifel 2017 Healthcare Conference

    LYNBROOK, N.Y., Nov. 7, 2017 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming Stifel 2017 Healthcare Conference on Tuesday, November 14, 2017 at 3:30 p.m. ET in New York, NY. BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for thirteen clinical indications to date.

  • Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : October 18, 2017
    Capital Cube4 months ago

    Biospecifics Technologies Corp. breached its 50 day moving average in a Bearish Manner : BSTC-US : October 18, 2017

    Categories: ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Biospecifics Technologies Corp.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bearish ... Read more (Read more...)

  • One Thing To Consider Before Buying BioSpecifics Technologies Corp (BSTC)
    Simply Wall St.5 months ago

    One Thing To Consider Before Buying BioSpecifics Technologies Corp (BSTC)

    If you are looking to invest in BioSpecifics Technologies Corp’s (NASDAQ:BSTC), or currently own the stock, then you need to understand its beta in order to understand how it canRead More...

  • PR Newswire5 months ago

    BioSpecifics Technologies Corp. to Present at the 2017 Cantor Fitzgerald Global Healthcare Conference

    LYNBROOK, N.Y., Sept. 20, 2017 /PRNewswire/ -- BioSpecifics Technologies Corp. (BSTC), a biopharmaceutical company that originated and continues to develop collagenase based-therapies with a first in class collagenase-based product marketed as XIAFLEX® in the U.S. and Xiapex® in Europe, today announced that BioSpecifics' President, Tom Wegman, will present a corporate overview at the upcoming 2017 Cantor Fitzgerald Global Healthcare Conference at 2:15 p.m. ET on Wednesday, September 27, 2017 in New York, NY. A live audio webcast of each presentation can also be accessed under the "Events and Presentation" tab in the Investors section of the Company's website at www.biospecifics.com or at http://wsw.com/webcast/cantor6/bstc. BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for thirteen clinical indications to date.

  • Should You Buy BioSpecifics Technologies Corp (BSTC) At This PE Ratio?
    Simply Wall St.5 months ago

    Should You Buy BioSpecifics Technologies Corp (BSTC) At This PE Ratio?

    BioSpecifics Technologies Corp (NASDAQ:BSTC) trades with a trailing P/E of 28.7x, which is lower than the industry average of 37.2x. While BSTC might seem like an attractive stock to buy,Read More...

  • Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017
    Capital Cube5 months ago

    Biospecifics Technologies Corp. :BSTC-US: Earnings Analysis: Q2, 2017 By the Numbers : September 13, 2017

    Categories: Yahoo FinanceGet free summary analysis Biospecifics Technologies Corp. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Biospecifics Technologies Corp. – AbbVie, Inc., Alder Biopharmaceuticals, Inc., Radius Health Inc, Abbott Laboratories, Eli Lilly and Company and Horizon Pharma plc (ABBV-US, ALDR-US, RDUS-US, ABT-US, LLY-US and ... Read more (Read more...)

  • New Strong Sell Stocks for September 5th
    Zacks6 months ago

    New Strong Sell Stocks for September 5th

    Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: